4C-MAR
Chemical compound
![]() | |
Identifiers | |
---|---|
| |
CAS Number |
|
PubChem CID |
|
Chemical and physical data | |
Formula | C10H11ClN2O |
Molar mass | 210.66 g·mol−1 |
3D model (JSmol) |
|
| |
InChI
|
4'-Chloro-4-methylaminorex (4C-MAR, 4'-Cl-4-MAR) is a recreational designer drug from the substituted aminorex family, with stimulant effects. It has reportedly been sold since around 2021 and was first definitively identified in Austria in January 2022.[1]
See also
- 2C-B-aminorex
- 2F-MAR
- 4B-MAR
- 4,4'-DMAR
- 4'-Fluoro-4-methylaminorex
- 4-Methylaminorex
- Clominorex
- MDMAR
- 4-Chloroamphetamine
- 4-Chloromethcathinone
References
- ^ Seibert E, Kunert O, Pferschy-Wenzig EM, Schmid MG (September 2022). "Characterization of Three Novel 4-Methylaminorex Derivatives Applied as Designer Drugs". Molecules. 27 (18). Basel, Switzerland: 5770. doi:10.3390/molecules27185770. PMC 9503756. PMID 36144500.
- v
- t
- e